Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
2002
Assessment of pain
2008 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Pancreatic cancer
2004 Standout
Bolus injection (2–4min) versus short-term (10–20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial
1998
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
2001
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
2004
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
The Burden and Determinants of Neck Pain in Workers
2008 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Drug penetration in solid tumours
2006 Standout
Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.
1997
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
1990 Standout
Back pain and associated factors in French nurses
1994
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
1999 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients
1987
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer
2002
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma
2001
Pancreatic Adenocarcinoma
2014 Standout
Cancer-associated cachexia
2018 Standout
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
1995
High prevalence of pain in patients with cancer in a large population-based study in The Netherlands
2007
Epirubicin
1993
Variability of tumor response to chemotherapy II. Contribution of tumor heterogeneity
1988
Cancer treatment and survivorship statistics, 2012
2012 Standout
Epirubicin
1993
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study
2007
New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the seventh world conference on lung cancer
1995
The role of gemcitabine alone and in combination in the treatment of pancreatic cancer
2000
Role of gemcitabine in cancer therapy
2005
Pancreatic Cancer
2010 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
2007 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
2007
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
2003 Standout
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma
2001
Epirubicin and doxorubicin comparative metabolism and pharmacokinetics
1988
Gemcitabine Combined With Oxaliplatin in Advanced Pancreatic Adenocarcinoma: Final Results of a GERCOR Multicenter Phase II Study
2002
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Chemotherapy of brain metastases: Current status
1984
Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study
2005
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?
2004
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
DIFFERENTIATION OF ENDOPLASMIC RETICULUM IN HEPATOCYTES
1971 StandoutNobel
Proposed mechanism of insulin-resistant glucose transport in the isolated guinea pig adipocyte. Small intracellular pool of glucose transporters.
1983 StandoutNobel
Attachment of Chloroplast Polysomes to Thylakoid Membranes in Chlamydomonas reinhardtii
1973 StandoutNobel
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
1997 StandoutScience
Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration
1986
BIOGENESIS OF ENDOPLASMIC RETICULUM MEMBRANES
1966 StandoutNobel
In vitro exchange of ribosomal subunits between free and membrane-bound ribosomes
1973 StandoutNobel
Etoposide pharmacokinetics in patients with normal and abnormal organ function.
1986
DIFFERENTIATION OF ENDOPLASMIC RETICULUM IN HEPATOCYTES
1971 StandoutNobel
GOLGI FRACTIONS PREPARED FROM RAT LIVER HOMOGENATES
1973 StandoutNobel
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
2007
Formation of Chloroplast Membranes in Chlamydomonas reinhardi y-1
1969 StandoutNobel
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
1987 Standout
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
2002
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma
2002
Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
2001 Standout
Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297
2002
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC).
1995 StandoutNobel
Turnover of Constituents of the Endoplasmic Reticulum Membranes of Rat Hepatocytes
1967 StandoutNobel
Mitoxantrone (novantrone): a review of experimental and early clinical studies
1983
Intracellular Aspects of the Process of Protein Synthesis
1975 StandoutScienceNobel
Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel
2005
Localization of a Prostaglandin F2a Receptor in Bovine Corpus luteum Plasma Membranes
1976 StandoutNobel
Etoposide (VP-16–213)
1985
Trends in the Aggressiveness of Cancer Care Near the End of Life
2004 Standout
Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.
1993
Effects of Phenobarbital on the Synthesis and Degradation of the Protein Components of Rat Liver Microsomal Membranes
1969 StandoutNobel
Metabolism of oxazaphosphorines
1988
Localization and Turnover Studies of Membrane Nicotinamide Adenine Dinucleotide Glycohydrolase in Rat Liver
1971 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Works of E. Piazza being referenced
Supportive care in patients with advanced non-small-cell lung cancer
2003
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
2004
High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study
1997
Ceravolo
2004
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
1999
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses
2000
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.
1980
A serological study of the cell fractions during the embryonic development of liver in chick
1963
Cisplatin-vinorelbine (DDP+VBN) association chemotherapy in the treatment of locally advanced N.S.C.L.C.
1994
Single-day regimen of palonosetron (PALO) and dexamethasone (DEX) for the prevention of emesis associated with moderately emetogenic chemotherapy (MEC): Subgroup analysis from a randomized phase III trial
2009
Pharmacokinetics of VP16-213 given by different administration methods
1982
[Analysis of the risk of backache in the occupational environment].
1986
Cross-over study of pharmacokinetics and haematological toxicity of 4'-epi-doxorubicin and doxorubicin in cancer patients.
1984
Adriamycin distribution in plasma and blood cells of cancer patients with altered hematocrit
1981
Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy.
1981